Filing Details
- Accession Number:
- 0000899243-16-032652
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-11-02 18:42:09
- Reporting Period:
- 2016-11-01
- Filing Date:
- 2016-11-02
- Accepted Time:
- 2016-11-02 18:42:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1273636 | Applied Genetic Technologies Corp | AGTC | Biological Products, (No Disgnostic Substances) (2836) | 593553710 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1598537 | D. Jeffrey Chulay | C/O Applied Genetic Technologies Corp. 14193 Nw 119Th Terrace, Suite #10 Alachua FL 32615 | Vp And Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-11-01 | 1,000 | $7.05 | 20,400 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2016.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.05 to $7.055, inclusive. The reporting person undertakes to provide to Applied Genetic Technologies Corporation ("AGTC"), any security holder of AGTC, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.